Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

SSX2 Protein (AA 1-188) (His tag)

SSX2 Origine: Humain Hôte: Escherichia coli (E. coli) Recombinant > 85 % by SDS - PAGE SDS
N° du produit ABIN6387445
  • Antigène Voir toutes SSX2 Protéines
    SSX2 (Synovial Sarcoma, X Breakpoint 2 (SSX2))
    Type de proteíne
    Recombinant
    Attributs du protein
    AA 1-188
    Origine
    Humain
    Source
    • 2
    • 1
    • 1
    Escherichia coli (E. coli)
    Purification/Conjugué
    Cette SSX2 protéine est marqué à la His tag.
    Application
    SDS-PAGE (SDS)
    Séquence
    MGSSHHHHHH SSGLVPRGSH RSMNGDDAFA RRPTVGAQIP EKIQKAFDDI AKYFSKEEWE KMKASEKIFY VYMKRKYEAM TKLGFKATLP PFMCNKRAED FQGNDLDNDP NRGNQVERPQ MTFGRLQGIS PKIMPKKPAE EGNDSEEVPE ASGPQNDGKE LCPPGKPTTS EKIHERSGPK RGEHAWTHRL RERKQLVIYE EISDPEEDDE
    Pureté
    > 85 % by SDS - PAGE
    Top Product
    Discover our top product SSX2 Protéine
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Commentaires

    Denatured

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.25 mg/mL
    Buffer
    Liquid. In 20  mM Tris-HCl buffer (  pH 8.0) containing 10 % glycerol, 0.4M urea
    Stock
    4 °C,-20 °C,-80 °C
    Stockage commentaire
    Can be stored at +4C short term (1-2 weeks). For long term storage, aliquot and store at -20C or -70C. Avoid repeated freezing and thawing cycles.
  • Antigène
    SSX2 (Synovial Sarcoma, X Breakpoint 2 (SSX2))
    Autre désignation
    SSX2 (SSX2 Produits)
    Synonymes
    CT5.2 Protein, CT5.2A Protein, HD21 Protein, HOM-MEL-40 Protein, SSX Protein, SSX2 Protein, SSX3 Protein, SSX family member 2 Protein, protein SSX2 Protein, synovial sarcoma, X breakpoint 2 Protein, SSX2 Protein, LOC741661 Protein, Ssx2 Protein
    Sujet
    SSX2 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneous humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. The encoded hybrid proteins are likely responsible for transforming activity. Alternative splicing of this gene results in multiple transcript variants. Recombinant human SSX2, fused to His-tag at N-terminus, was expressed in E.coli .
    Poids moléculaire
    24.0 kDa (210 aa)
    NCBI Accession
    NP_001157889
    UniProt
    Q16385
Vous êtes ici:
Support technique